Development
NeuroOne Medical Technologies Corporation
NMTC
$0.5817
-$0.0073-1.24%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 977.60K | 741.80K | 629.90K | 466.20K | 1.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 977.60K | 741.80K | 629.90K | 466.20K | 1.57M |
| Cost of Revenue | 2.19M | 2.33M | 2.28M | 2.14M | 1.69M |
| Gross Profit | -1.22M | -1.59M | -1.65M | -1.67M | -120.60K |
| SG&A Expenses | 2.17M | 1.58M | 1.86M | 1.82M | 1.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.37M | 3.91M | 4.14M | 3.96M | 3.35M |
| Operating Income | -3.39M | -3.16M | -3.51M | -3.50M | -1.78M |
| Income Before Tax | -3.34M | -3.14M | -3.47M | -3.52M | -1.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.34M | -3.14M | -3.47M | -3.52M | -1.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.34M | -3.14M | -3.47M | -3.52M | -1.73M |
| EBIT | -3.39M | -3.16M | -3.51M | -3.50M | -1.78M |
| EBITDA | -3.33M | -3.10M | -3.45M | -3.45M | -1.75M |
| EPS Basic | -0.14 | -0.14 | -0.20 | -0.21 | -0.11 |
| Normalized Basic EPS | -0.09 | -0.09 | -0.12 | -0.13 | -0.07 |
| EPS Diluted | -0.14 | -0.14 | -0.20 | -0.21 | -0.11 |
| Normalized Diluted EPS | -0.09 | -0.09 | -0.12 | -0.13 | -0.07 |
| Average Basic Shares Outstanding | 24.00M | 22.26M | 17.58M | 16.41M | 16.23M |
| Average Diluted Shares Outstanding | 24.00M | 22.26M | 17.58M | 16.41M | 16.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |